{"product_id":"saphnelo-frasco-300mg-2ml-ampulas-anifrolumab","title":"Saphnelo Vial 300mg 2ml Ampoules (Anifrolumab)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eImmunosuppressants\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eTreatment of autoimmune diseases\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eSaphnelo\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eAnifrolumab\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e300 mg in 2 ml vial in ampoules\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eAstrazeneca\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eSaphnelo (anifrolumab) is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who have disease activity despite receiving standard treatment. This medication is indicated in patients who have experienced adverse effects to other medications or who have not achieved adequate symptom control with previous treatments. Anifrolumab acts as an interferon signaling inhibitor, which helps reduce inflammation and damage associated with SLE. It has been shown to improve disease activity, quality of life, and decrease the need for corticosteroids in these patients.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Saphnelo vial contains 300 mg of anifrolumab, as well as excipients necessary for the formulation.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eThis medication is contraindicated in patients with known hypersensitivity to anifrolumab or to any of the components of the formula. Its use is not recommended in patients with active infections, as it may increase the risk of complications due to its immunosuppressive effect.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eThe following precautions should be considered when using Saphnelo: regular monitoring for infections, evaluation of tuberculosis history, and monitoring for hematological adverse effects. It is important to perform laboratory tests periodically to assess renal and liver function in patients undergoing treatment.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in refrigeration between 2 °C and 8 °C. Do not freeze. Keep the vial in its original packaging to protect it from light. Do not use after the expiration date indicated on the package.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Astrazeneca","offers":[{"title":"Default Title","offer_id":45848500240609,"sku":"5000456076821","price":30627.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/5000456076821_f66f16d0-f529-468e-a226-dbca5fc7e527.jpg?v=1744689523","url":"https:\/\/wecarepharma.mx\/en\/products\/saphnelo-frasco-300mg-2ml-ampulas-anifrolumab","provider":"WeCare Pharma","version":"1.0","type":"link"}